統計的有意性と P 値に関する ASA 声明

1 1 Wasserstein RL, Lazar NA. Editorial: The ASA s statement on p-values: Context, process, and purpose. The american Statistician 2016; 70: 129-133. The ASA Statement of Statistical Significance and P-Values , 2017 4 23 P ASA 1. P P P P P american Statistical Association, ASA P 2.

2 P ? P 2 3. 1. P : P 2 P 2 P P 2. P P P P 3. P : P P P 4.

3 P P P P P P P 5. P P 3 P P P P 6. P P P P P P 4.

4 P P P P False Discovery Rate P 5. ASA Naomi Altman, Jim Berger, Yoav Benjamini, Don Berry, Brad Carlin, John Carlin, George Cobb, Marie Davidian, Steve Fienberg, Andrew Gelman, Steve Goodman, Sander Greenland, Guido Imbens, John Ioannidis, Valen Johnson, Michael Lavine, Michael Lew, Rod Little, Deborah Mayo, Chuck McCulloch, Michele Millar, Sally Morton, Regina Nuzzo, Hilary Parker, Kenneth Rothman, Don Rubin, Stephen Senn, Uri Simonsohn, Dalene Stangl, Philip Stark.

5 Steve Ziliak Ronald L. Wasserman 4 P Altman , and Bland (1995), Absence of Evidence is not Evidence of Absence, British Medical Journal, 311, 485. Altman, , Machin, D., Bryant, , and Gardner, (eds.) (2000), Statistics with Confidence (2nd ed.), London: BMJ Books. Berger, , and Delampady, M. (1987), Testing Precise Hypotheses, Statistical Science, 2, 317 335. Berry, D. (2012), Multiplicities in Cancer Research: Ubiquitous and Necessary Evils, Journal of the National Cancer Institute, 104, 1124 1132. Christensen, R. (2005), Testing Fisher, Neyman, Pearson, and Bayes, The american Statistician, 59, 121 126. Cox, (1982), Statistical Significance Tests, British Journal of Clinical Pharmacology, 14, 325 331.

6 Edwards, W., Lindman, H., and Savage, (1963), Bayesian Statistical Inference for Psychological Research, Psychological Review, 70, 193 242. Gelman, A., and Loken, E. (2014), The Statistical Crisis in Science [online], american Scientist, 102. Available at Gelman, A., and Stern, (2006), The Difference Between Significant and Not Significant is not Itself Statistically Significant, The american Statistician, 60, 328 331. Gigerenzer, G. (2004), Mindless Statistics, Journal of Socioeconomics, 33, 567 606. Goodman, (1999a), Toward Evidence-BasedMedical Statistics 1: The P-Va l u e Fallacy, Annals of Internal Medicine, 130, 995 1004. (1999b), Toward Evidence-Based Medical Statistics.

7 2: The Bayes Factor, Annals of Internal Medicine, 130, 1005 1013. (2008), A Dirty Dozen: Twelve P-Va l u e Misconceptions, Seminars in Hematology, 45, 135 140. Greenland, S. (2011), Null Misinterpretation in Statistical Testing and its Impact on Health Risk Assessment, Preventive Medicine, 53, 225 228. (2012), Nonsignificance Plus High Power Does Not Imply Support for the Null Over the Alternative, Annals of Epidemiology, 22, 364 368. Greenland, S., and Poole, C. (2011), Problems in Common Interpretations of Statistics in Scientific Articles, Expert Reports, and Testimony, Jurimetrics, 51, 113 129. Hoenig, , and Heisey, (2001), The Abuse of Power: The Pervasive Fallacy of Power Calculations for Data Analysis, The american Statistician, 55, 19 24.

8 Ioannidis, (2005), Contradicted and Initially Stronger Effects in Highly Cited Clinical Research, Journal of the american Medical Association, 294, 218 228. (2008), Why Most Discovered True Associations are Inflated (with discussion), Epidemiology 19, 640 658. Johnson, (2013), Revised Standards for Statistical Evidence, Proceedings of the National Academy of Sciences, 110(48), 19313 19317. (2013), Uniformly Most Powerful Bayesian Tests, Annals of Statistics, 41, 1716 1741. Lang, J., Rothman , and Cann, (1998), That Confounded P-value (editorial), Epidemiology, 9, 7 8. Lavine, M. (1999), What is Bayesian Statistics and Why Everything Else is Wrong, UMAP 5 Journal, 20, 2. Lew, (2012), Bad Statistical Practice in Pharmacology (and Other Basic Biomedical Disciplines): You Probably Don t Know P, British Journal of Pharmacology, 166, 5, 1559 1567.

9 Phillips, (2004), Publication Bias In Situ, BMC Medical Research Methodology, 4, 20. Poole, C. (1987), Beyond the Confidence Interval, american Journal of Public Health, 77, 195 199. (2001), Low P-values or Narrow Confidence Intervals: Which are More Durable? Epidemiology, 12, 291 294. Rothman, (1978), A Show of Confidence (editorial), New England Journal of Medicine, 299, 1362 1363. (1986), Significance Questing (editorial), Annals of Internal Medicine, 105, 445 447. (2010), Curbing Type I and Type II Errors, European Journal of Epidemiology, 25, 223 224. Rothman, , Weiss, , Robins, J., Neutra, R., and Stellman, S. (1992), Amicus Curiae Brief for the U. S. Supreme Court, Daubert v. Merrell Dow Pharmaceuticals, Petition for Writ of Certiorari to the United States Court of Appeals for the Ninth Circuit, No.

10 92-102, October Term, 1992. Rozeboom, (1960), The Fallacy of the Null-Hypothesis Significance Test, Psychological Bulletin, 57, 416 428. Schervish, (1996), P-Values: What They Are and What They Are Not, The american Statistician, 50, 203 206. Simmons, , Nelson, , and Simonsohn, U. (2011), False-Positive Psychology: Undisclosed Flexibility in Data Collection and Analysis Allows Presenting Anything as Significant, Psychological Science, 22, 1359 1366. Stang, A., and Rothman, (2011), That Confounded P-value Revisited, Journal of Clinical Epidemiology, 64, 1047 1048. Stang, A., Poole, C., and Kuss, O. (2010), The Ongoing Tyranny of Statistical Significance Testing in Biomedical Research, European Journal of Epidemiology, 25, 225 230.